This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!
Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

NIH NLM Logo
Log in
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Nov 15;12(11):e0006837.
doi: 10.1371/journal.pntd.0006837. eCollection 2018 Nov.

Creative use of the priority review voucher by public and not-for-profit actors delivers the first new FDA-approved treatment for river blindness in 20 years

Affiliations

Creative use of the priority review voucher by public and not-for-profit actors delivers the first new FDA-approved treatment for river blindness in 20 years

Piero L Olliaro et al. PLoS Negl Trop Dis. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist. PLO, ACK, CMH, and JCR are staff members of the World Health Organization (WHO). MS is founder and managing director of Medicine Development for Global Health. The authors alone are responsible for the views expressed in this publication and do not necessarily represent the decisions, policy, or views of WHO.

References

    1. World Health Organization (WHO). Accelerating work to overcome the global impact of neglected tropical diseases: A roadmap for implementation. 2012. http://apps.who.int/iris/bitstream/handle/10665/70809/WHO_HTM_NTD_2012.1.... [cited 2018 August 28].
    1. Policy cures Research. G-Finder 2017. Neglected disease research and development. Reflecting on a decade of global investment. http://policycuresresearch.org/downloads/Y10_G-FINDER_full_report.pdf. [cited 2018 August 28].
    1. Trouiller P, Olliaro P, Torreele E, Orbinski J, Laing R, Ford N. Drug development for neglected diseases: a deficient market and a public-health policy failure. Lancet. 2002. June 22;359(9324):2188–94. 10.1016/S0140-6736(02)09096-7 - DOI - PubMed
    1. Pedrique B, Strub-Wourgaft N, Some C, Olliaro P, Trouiller P, Ford N, et al. The drug and vaccine landscape for neglected diseases (2000–11): a systematic assessment. Lancet Glob Health. 2013. December;1(6):e371–9. 10.1016/S2214-109X(13)70078-0 - DOI - PubMed
    1. US Department of Health and Human Services. US Food and Drug Administration website. Food and Drug Administration Amendments Act (FDAAA) of 2007. https://www.fda.gov/RegulatoryInformation/LawsEnforcedbyFDA/SignificantA.... [cited 2018 August 28].

MeSH terms

Full text links
Public Library of Science full text link Public Library of Science Free PMC article
Cite

AltStyle によって変換されたページ (->オリジナル) /